Extended-Release Mesalamine Granules for Ulcerative Colitis

Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials

(2012) G. R. Lichtenstein et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Inaccuracies concerning Salofalk granules

(2011) M. Moerike   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis

(2011) L. Leifeld et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial

(2010) G. R. Lichtenstein et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

(2010) Asher Kornbluth et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial

(2010) Volker Gross et al.   Journal of Crohns & Colitis

5-ASA in ulcerative colitis: Improving treatment compliance

(2009) Cosimo Prantera et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Multi-Matrix System Mesalamine: To Use or Not To Use

(2008) Pramodini B Kale-Pradhan et al.   ANNALS OF PHARMACOTHERAPY

Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults

(2008) Michael D. Kappelman et al.   GASTROENTEROLOGY

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

(2008) W Kruis et al.   GUT